Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06954753

Predicting Cancer in Pancreatic Cystic Lesions Through Artificial Intelligence

Deep Learning for Malignant Degeneration Prediction of Pancreatic Cystic Lesions - Beyond High-risk Stigmata

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
250 (estimated)
Sponsor
Centre Hospitalier Universitaire de Nice · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This international, multicenter retrospective study aims to develop a deep learning (DL)-based predictive model to identify malignant transformation in pancreatic cystic lesions, improving upon current clinical guidelines. The model will integrate clinical, biochemical, and multimodal imaging data. Several 3D convolutional neural networks will be trained using advanced preprocessing, data augmentation, and hybrid fusion techniques. Model performance will be compared to that of existing international guidelines. The study involves no additional procedures for patients and adheres to strict data anonymization and privacy regulations.

Conditions

Interventions

TypeNameDescription
PROCEDUREPancreatic surgeryPancreatic resective surgery performed for pancreatic cystic lesions with high risk of malignant degeneration based on clinical, biochemical, and/or radiological features following current guidelines on pancreatic cystic lesions management.

Timeline

Start date
2025-06-01
Primary completion
2026-06-01
Completion
2026-12-31
First posted
2025-05-02
Last updated
2025-05-02

Source: ClinicalTrials.gov record NCT06954753. Inclusion in this directory is not an endorsement.